StonvexLoading…
StonvexStonvexStonvexCore line items from CLRO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $4.23M |
Operating Income | $-850.00K | $-4.40M | $-3.26M | $-7.41M |
Net Income | $-487.00K | $-26.08M | $-21.14M | $-7.41M |
EPS (Diluted) | $-0.18 | $-14.77 | $-12.39 | $-4.38 |
Total Assets | $2.02M | $2.30M | $9.47M | $24.00M |
Total Liabilities | $1.49M | $3.01M | $5.25M | $9.06M |
Cash & Equivalents | $756.00K | $220.00K | $101.00K | $1.13M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-3.34M | $-2.58M |
Shares Outstanding | 2.68M | 2.24M | 1.73M | 1.73M |